Benzyloxy anilide derivatives useful as potassium channel modulators

Details for Australian Patent Application No. 2009271302 (hide)

Owner Valeant Pharmaceuticals International

Inventors Song, Jianlan; Chen, Huanming; Wu, Jim Zhen; Vernier, Jean-Michel

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009271302

PCT Pub. Number WO2010/008894

Priority 61/075,307 24.06.08 US

Filing date 24 June 2009

Wipo publication date 21 January 2010

International Classifications

C07D 213/30 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2010/008894 Priority application(s): WO2010/008894

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009271304-Low-energy 4-cell electrochemical system with carbon dioxide gas

2009271299-Anthelminthic formulations